Coldstream Capital Management’s Lifecore Biomedical LFCR Stock Holding History

Coldstream Capital Management’s Portfolio LFCR Stock Details LFCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-14,735	Closed	-$203K	–	156
2014 Q4	$203K	Sell	14,735 -1,390	-9%	-$18K	0.06%	169
2014 Q3	$198K	Sell	16,125 -4,170	-21%	-$52.1K	0.06%	161
2014 Q2	$253K	Hold	20,295	–	–	0.07%	142
2014 Q1	$226K	Buy	20,295 +1,945	+11%	+$21.3K	0.07%	149
2013 Q4	$222K	Buy	18,350 +6,630	+57%	+$79.2K	0.07%	151
2013 Q3	$143K	Sell	11,720 -1,140	-9%	-$15.9K	0.05%	165
2013 Q2	$170K	Buy	+12,860	New	+$178K	0.06%	163

Other funds holding LFCR

Wynnefield Capital New York $148M AUM 32.71% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

NIMC

NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return

Killen Group Berwyn, Pennsylvania $866M AUM 0.25% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Coldstream Capital Management's LFCR Position: Q1 2015 in Review

Coldstream Capital Management sold out of Lifecore Biomedical (LFCR) in Q1 2015, closing a stake of 14,735 shares — an estimated $203K sold.

Coldstream Capital Management first reported a position in LFCR in Q2 2013 and held it in 7 quarters. The position peaked at $253K in Q2 2014. 99 funds tracked by Wall St. Rank hold LFCR as of Q1 2015.

Coldstream Capital Management reported no remaining Lifecore Biomedical position as of Q1 2015 after selling out during the quarter.
Coldstream Capital Management sold 14,735 Lifecore Biomedical shares in Q1 2015, an estimated $203K.
Coldstream Capital Management first reported a position in Lifecore Biomedical in Q2 2013 and held it in 7 quarters.
Coldstream Capital Management's Lifecore Biomedical position peaked at $253K in Q2 2014.
99 funds tracked by Wall St. Rank held Lifecore Biomedical as of Q1 2015.

Based on Coldstream Capital Management's 13F filing for Q1 2015, filed 11 May 2015.